2 Deaths Prompt FDA Probe Of Eli Lilly's Zyprexa Relprevv
The U.S. Food and Drug Administration on Tuesday said it has opened an investigation after two patients died following injections of Eli Lilly & Co.'s schizophrenia drug Zyprexa Relprevv, the latest...To view the full article, register now.
Already a subscriber? Click here to view full article